| Clinical data | |
|---|---|
| Other names | 5-spiro-(2'-ethyl-3'-5'-dimethyl-cyclopentyl)barbituric acid |
| ATC code |
|
| Identifiers | |
| |
| CAS Number |
|
| UNII |
|
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C12H18N2O3 |
| Molar mass | 238.287 g·mol−1 |
| 3D model (JSmol) | |
| |
| (verify) | |
Spirobarbital is abarbiturate derivative developed byEli Lilly in the 1940s.[1] It hashypnotic andsedative effects, and has a moderate potential for abuse.[2]